| Loss of PTEN promotes resistance to T cell–mediated immunotherapy W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ... Cancer discovery 6 (2), 202-216, 2016 | 1461 | 2016 |
| BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma DT Frederick, A Piris, AP Cogdill, ZA Cooper, C Lezcano, CR Ferrone, ... Clinical cancer research 19 (5), 1225-1231, 2013 | 1008 | 2013 |
| PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines W Peng, C Liu, C Xu, Y Lou, J Chen, Y Yang, H Yagita, WW Overwijk, ... Cancer research 72 (20), 5209-5218, 2012 | 511 | 2012 |
| Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients LG Radvanyi, C Bernatchez, M Zhang, PS Fox, P Miller, J Chacon, R Wu, ... Clinical Cancer Research 18 (24), 6758-6770, 2012 | 480 | 2012 |
| BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice C Liu, W Peng, C Xu, Y Lou, M Zhang, JA Wargo, JQ Chen, HS Li, ... Clinical cancer research 19 (2), 393-403, 2013 | 418 | 2013 |
| Plasmacytoid dendritic cells induce NK cell–dependent, tumor antigen–specific T cell cross-priming and tumor regression in mice C Liu, Y Lou, G Lizée, H Qin, S Liu, B Rabinovich, GJ Kim, YH Wang, Y Ye, ... The Journal of clinical investigation 118 (3), 1165-1175, 2008 | 406 | 2008 |
| Oncogenic BRAF (V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma JS Khalili, S Liu, TG Rodríguez-Cruz, M Whittington, S Wardell, C Liu, ... Clinical Cancer Research 18 (19), 5329-5340, 2012 | 327 | 2012 |
| Loss of PTEN promotes resistance to T cell-mediated immunotherapy. Cancer Discov. 2016; 6: 202–216. doi: 10.1158/2159-8290 W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ... CD-15-0283.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 2018 | 310 | 2018 |
| NLRC5/MHC class I transactivator is a target for immune evasion in cancer S Yoshihama, J Roszik, I Downs, TB Meissner, S Vijayan, B Chapuy, ... Proceedings of the National Academy of Sciences 113 (21), 5999-6004, 2016 | 265 | 2016 |
| Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain G Lizée, G Basha, J Tiong, JP Julien, M Tian, KE Biron, WA Jefferies Nature immunology 4 (11), 1065-1073, 2003 | 257 | 2003 |
| Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses W Peng, Y Ye, BA Rabinovich, C Liu, Y Lou, M Zhang, M Whittington, ... Clinical Cancer Research 16 (22), 5458-5468, 2010 | 248 | 2010 |
| Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity Y Hailemichael, DH Johnson, N Abdel-Wahab, WC Foo, SE Bentebibel, ... Cancer Cell 40 (5), 509-523. e6, 2022 | 206 | 2022 |
| Harnessing the power of the immune system to target cancer G Lizée, WW Overwijk, L Radvanyi, J Gao, P Sharma, P Hwu Annual review of medicine 64 (1), 71-90, 2013 | 189 | 2013 |
| Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11-Dependent Manner JS Khalili, X Yu, J Wang, BC Hayes, MA Davies, G Lizee, B Esmaeli, ... Clinical Cancer Research 18 (16), 4345-4355, 2012 | 185 | 2012 |
| BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma SD Bradley, Z Chen, B Melendez, A Talukder, JS Khalili, ... Cancer immunology research 3 (6), 602-609, 2015 | 167 | 2015 |
| Human dendritic cells in cancer G Lizée, M Gilliet Innate Immune Regulation and Cancer Immunotherapy, 121-145, 2012 | 167 | 2012 |
| Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression G Lizée, JL Aerts, MI Gonzales, N Chinnasamy, RA Morgan, SL Topalian Human gene therapy 14 (6), 497-507, 2003 | 164 | 2003 |
| Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo Y Lou, G Wang, G Lizée, GJ Kim, SE Finkelstein, C Feng, NP Restifo, ... Cancer research 64 (18), 6783-6790, 2004 | 146 | 2004 |
| RNA editing derived epitopes function as cancer antigens to elicit immune responses M Zhang, J Fritsche, J Roszik, LJ Williams, X Peng, Y Chiu, CC Tsou, ... Nature communications 9 (1), 3919, 2018 | 140 | 2018 |
| HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes RM Mbofung, JA McKenzie, S Malu, M Zhang, W Peng, C Liu, I Kuiatse, ... Nature communications 8 (1), 451, 2017 | 134 | 2017 |
WILLEM W OVERWIJKNektar TherapeuticsVerified email at nektar.com
